Extreme CD8 T Cell Requirements for Anti-Malarial Liver-Stage Immunity following Immunization with Radiation Attenuated Sporozoites


Radiation-attenuated Plasmodium sporozoites (RAS) are the only vaccine shown to induce sterilizing protection against malaria in both humans and rodents. Importantly, these “whole-parasite” vaccines are currently under evaluation in human clinical trials. Studies with inbred mice reveal that RAS-induced CD8 T cells targeting liver-stage parasites are critical for protection. However, the paucity of defined T cell epitopes for these parasites has precluded precise understanding of the specific characteristics of RAS-induced protective CD8 T cell responses. Thus, it is not known whether quantitative or qualitative differences in RAS-induced CD8 T cell responses underlie the relative resistance or susceptibility of immune inbred mice to sporozoite challenge. Moreover, whether extraordinarily large CD8 T cell responses are generated and required for protection following RAS immunization, as has been described for CD8 T cell responses following single-antigen subunit vaccination, remains unknown. Here, we used surrogate T cell activation markers to identify and track whole-parasite, RAS-vaccine-induced effector and memory CD8 T cell responses. Our data show that the differential susceptibility of RAS-immune inbred mouse strains to Plasmodium berghei or P. yoelii sporozoite challenge does not result from host- or parasite-specific decreases in the CD8 T cell response. Moreover, the surrogate activation marker approach allowed us for the first time to evaluate CD8 T cell responses and protective immunity following RAS-immunization in outbred hosts. Importantly, we show that compared to a protective subunit vaccine that elicits a CD8 T cell response to a single epitope, diversifying the targeted antigens through whole-parasite RAS immunization only minimally, if at all, reduced the numerical requirements for memory CD8 T cell-mediated protection. Thus, our studies reveal that extremely high frequencies of RAS-induced memory CD8 T cells are required, but may not suffice, for sterilizing anti-Plasmodial immunity. These data provide new insights into protective CD8 T cell responses elicited by RAS-immunization in genetically diverse hosts, information with relevance to developing attenuated whole-parasite vaccines.


Vyšlo v časopise: Extreme CD8 T Cell Requirements for Anti-Malarial Liver-Stage Immunity following Immunization with Radiation Attenuated Sporozoites. PLoS Pathog 6(7): e32767. doi:10.1371/journal.ppat.1000998
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000998

Souhrn

Radiation-attenuated Plasmodium sporozoites (RAS) are the only vaccine shown to induce sterilizing protection against malaria in both humans and rodents. Importantly, these “whole-parasite” vaccines are currently under evaluation in human clinical trials. Studies with inbred mice reveal that RAS-induced CD8 T cells targeting liver-stage parasites are critical for protection. However, the paucity of defined T cell epitopes for these parasites has precluded precise understanding of the specific characteristics of RAS-induced protective CD8 T cell responses. Thus, it is not known whether quantitative or qualitative differences in RAS-induced CD8 T cell responses underlie the relative resistance or susceptibility of immune inbred mice to sporozoite challenge. Moreover, whether extraordinarily large CD8 T cell responses are generated and required for protection following RAS immunization, as has been described for CD8 T cell responses following single-antigen subunit vaccination, remains unknown. Here, we used surrogate T cell activation markers to identify and track whole-parasite, RAS-vaccine-induced effector and memory CD8 T cell responses. Our data show that the differential susceptibility of RAS-immune inbred mouse strains to Plasmodium berghei or P. yoelii sporozoite challenge does not result from host- or parasite-specific decreases in the CD8 T cell response. Moreover, the surrogate activation marker approach allowed us for the first time to evaluate CD8 T cell responses and protective immunity following RAS-immunization in outbred hosts. Importantly, we show that compared to a protective subunit vaccine that elicits a CD8 T cell response to a single epitope, diversifying the targeted antigens through whole-parasite RAS immunization only minimally, if at all, reduced the numerical requirements for memory CD8 T cell-mediated protection. Thus, our studies reveal that extremely high frequencies of RAS-induced memory CD8 T cells are required, but may not suffice, for sterilizing anti-Plasmodial immunity. These data provide new insights into protective CD8 T cell responses elicited by RAS-immunization in genetically diverse hosts, information with relevance to developing attenuated whole-parasite vaccines.


Zdroje

1. BryceJ

Boschi-PintoC

ShibuyaK

BlackRE

2005

WHO estimates of the causes of death in children.

Lancet

365

1147

1152

2. HaySI

SnowRW

2006

The Malaria Atlas Project: Developing Global Maps of Malaria Risk.

PLoS Med

3

e473

3. SachsJ

MalaneyP

2002

The economic and social burden of malaria.

Nature

415

680

685

4. SnowRW

GuerraCA

NoorAM

MyintHY

HaySI

2005

The global distribution of clinical episodes of Plasmodium falciparum malaria.

Nature

434

214

217

5. GuerraCA

SnowRW

HaySI

2006

Mapping the global extent of malaria in 2005.

Trends Parasitol

22

353

358

6. TodrykSM

HillAV

2007

Malaria vaccines: the stage we are at.

Nat Rev Microbiol

5

487

489

7. ClydeDF

1975

Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.

Am J Trop Med Hyg

24

397

401

8. HoffmanSL

GohLM

LukeTC

SchneiderI

LeTP

2002

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.

J Infect Dis

185

1155

1164

9. NussenzweigRS

VanderbergJ

MostH

OrtonC

1967

Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei.

Nature

216

160

162

10. ButlerD

2009

Initiative targets malaria eradication.

Nature

462

19

11. DoolanDL

HoffmanSL

2000

The complexity of protective immunity against liver-stage malaria.

J Immunol

165

1453

1462

12. WeissWR

BerzofskyJA

HoughtenRA

SedegahM

HollindaleM

1992

A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei.

J Immunol

149

2103

2109

13. RomeroP

MaryanskiJL

CorradinG

NussenzweigRS

NussenzweigV

1989

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria.

Nature

341

323

326

14. GrunerAC

MauduitM

TewariR

RomeroJF

DepinayN

2007

Sterile protection against malaria is independent of immune responses to the circumsporozoite protein.

PLoS One

2

e1371

15. KumarKA

SanoG

BoscardinS

NussenzweigRS

NussenzweigMC

2006

The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites.

Nature

444

937

940

16. SchmidtNW

PodyminoginRL

ButlerNS

BadovinacVP

TuckerBJ

2008

Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria.

Proc Natl Acad Sci U S A

105

14017

14022

17. MillerJD

van der MostRG

AkondyRS

GlidewellJT

AlbottS

2008

Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.

Immunity

28

710

722

18. RaiD

PhamNL

HartyJT

BadovinacVP

2009

Tracking the Total CD8 T Cell Response to Infection Reveals Substantial Discordance in Magnitude and Kinetics between Inbred and Outbred Hosts.

J Immunol

183

7672

7681

19. RieckmannKH

1990

Human immunization with attenuated sporozoites.

Bull World Health Organ

68

Suppl

13

16

20. WeissWR

GoodMF

HollingdaleMR

MillerLH

BerzofskyJA

1989

Genetic control of immunity to Plasmodium yoelii sporozoites.

J Immunol

143

4263

4266

21. KaechSM

HembyS

KershE

AhmedR

2002

Molecular and functional profiling of memory CD8 T cell differentiation.

Cell

111

837

851

22. BuschDH

PilipIM

VijhS

PamerEG

1998

Coordinate regulation of complex T cell populations responding to bacterial infection.

Immunity

8

353

362

23. VanderbergJP

NussenzweigRS

MostH

1968

Further studies on the Plasmodium berghei-Anopheles stephensi–rodent system of mammalian malaria.

J Parasitol

54

1009

1016

24. ZechiniB

CordierL

NgonseuE

D'AlessandroU

WeryM

1999

Plasmodium berghei development in irradiated sporozoite-immunized C57BL6 mice.

Parasitology

118 ( Pt 4)

335

338

25. SchellerLF

AzadAF

1995

Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites.

Proc Natl Acad Sci U S A

92

4066

4068

26. BerenzonD

SchwenkRJ

LetellierL

Guebre-XabierM

WilliamsJ

2003

Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells.

J Immunol

171

2024

2034

27. NussenzweigR

VanderbergJ

MostH

1969

Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity.

Mil Med

134

1176

1182

28. NussenzweigRS

VanderbergJP

MostH

OrtonC

1969

Specificity of protective immunity produced by x-irradiated Plasmodium berghei sporozoites.

Nature

222

488

489

29. OliveiraGA

KumarKA

Calvo-CalleJM

OthoroC

AltszulerD

2008

Class II-restricted protective immunity induced by malaria sporozoites.

Infect Immun

76

1200

1206

30. DoolanDL

HoffmanSL

1999

IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.

J Immunol

163

884

892

31. LabaiedM

HarupaA

DumpitRF

CoppensI

MikolajczakSA

2007

Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection.

Infect Immun

75

3758

3768

32. SedegahM

WeissWW

HoffmanSL

2007

Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites.

Parasite Immunol

29

559

565

33. TarunAS

DumpitRF

CamargoN

LabaiedM

LiuP

2007

Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.

J Infect Dis

196

608

616

34. KhanZM

VanderbergJP

1992

Specific inflammatory cell infiltration of hepatic schizonts in BALB/c mice immunized with attenuated Plasmodium yoelii sporozoites.

Int Immunol

4

711

718

35. KumarKA

BaxterP

TarunAS

KappeSH

NussenzweigV

2009

Conserved protective mechanisms in radiation and genetically attenuated uis3(-) and uis4(-) Plasmodium sporozoites.

PLoS One

4

e4480

36. ChattopadhyayR

ContehS

LiM

JamesER

EpsteinJE

2009

The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine.

Vaccine

27

3675

3680

37. TrimnellA

TakagiA

GuptaM

RichieTL

KappeSH

2009

Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.

J Immunol

183

5870

5878

38. SchofieldL

VillaquiranJ

FerreiraA

SchellekensH

NussenzweigR

1987

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites.

Nature

330

664

666

39. WherryEJ

TeichgraberV

BeckerTC

MasopustD

KaechSM

2003

Lineage relationship and protective immunity of memory CD8 T cell subsets.

Nat Immunol

4

225

234

40. TomiyamaH

TakataH

MatsudaT

TakiguchiM

2004

Phenotypic classification of human CD8+ T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function.

Eur J Immunol

34

999

1010

41. KuCC

MurakamiM

SakamotoA

KapplerJ

MarrackP

2000

Control of homeostasis of CD8+ memory T cells by opposing cytokines.

Science

288

675

678

42. SchmidtNW

ButlerNS

HartyJT

2009

CD8 T cell immunity to Plasmodium permits generation of protective antibodies after repeated sporozoite challenge.

Vaccine

27

6103

6106

43. BrionesMR

TsujiM

NussenzweigV

1996

The large difference in infectivity for mice of Plasmodium berghei and Plasmodium yoelii sporozoites cannot be correlated with their ability to enter into hepatocytes.

Mol Biochem Parasitol

77

7

17

44. CockburnIA

ChenYC

OverstreetMG

LeesJR

van RooijenN

2010

Prolonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasites.

PLoS Pathog

6

e1000877

45. JobeO

LumsdenJ

MuellerAK

WilliamsJ

Silva-RiveraH

2007

Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells.

J Infect Dis

196

599

607

46. AlyAS

MikolajczakSA

RiveraHS

CamargoN

Jacobs-LorenaV

2008

Targeted deletion of SAP1 abolishes the expression of infectivity factors necessary for successful malaria parasite liver infection.

Mol Microbiol

69

152

163

47. VaughanAM

O'NeillMT

TarunAS

CamargoN

PhuongTM

2009

Type II fatty acid synthesis is essential only for malaria parasite late liver stage development.

Cell Microbiol

11

506

520

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 7
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa